Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT00241020 · COMPLETED
Trial details
- NCT number
- NCT00241020
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2005-10-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.